Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Use of synthetic slings and mesh implants in the treatment of female stress urinary incontinence and prolapse : Statement of the Working Group on Urological Functional Diagnostics and Female Urology of the Academy of the German Society of Urology].
Höfner K, Hampel C, Kirschner-Hermanns R, Alloussi SH, Bauer RM, Bross S, Bschleipfer T, Goepel M, Haferkamp A, Hüsch T, Kaufmann A, Kiss G, Kranz J, Oelke M, Pannek J, Reitz A, Rutkowski M, Schäfer W, Schulte-Baukloh H, Schumacher S, Seif C, Schultz-Lampel D. Höfner K, et al. Among authors: schulte baukloh h. Urologe A. 2020 Jan;59(1):65-71. doi: 10.1007/s00120-019-01074-y. Urologe A. 2020. PMID: 31741004 German.
Botulinumtoxin for bladder disorders.
Schulte-Baukloh H, Bauer R, Jost W, Wissel J, van Ophoven A. Schulte-Baukloh H, et al. Fortschr Neurol Psychiatr. 2019 Feb;87(1):23-30. doi: 10.1055/a-0599-0697. Epub 2018 Dec 3. Fortschr Neurol Psychiatr. 2019. PMID: 30508871 Review. German.
Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study.
Kennelly M, Dmochowski R, Schulte-Baukloh H, Ethans K, Del Popolo G, Moore C, Jenkins B, Guard S, Zheng Y, Karsenty G; 191622-094 Investigators. Kennelly M, et al. Among authors: schulte baukloh h. Neurourol Urodyn. 2017 Feb;36(2):368-375. doi: 10.1002/nau.22934. Epub 2015 Nov 24. Neurourol Urodyn. 2017. PMID: 26607743 Clinical Trial.
Efficacité et innocuité à long terme des injections répétées d'OnabotulinumtoxinA (BOTOX(®)) chez des patients souffrant d'hyperactivité du détrusor d'origine neurologique : résultats finaux d'un suivi longitudinal jusqu'à 4ans.
Karsenty G, Schulte-Baukloh H, Dmochowski R, Ethans K, Brenda J, Guard S, Zheng Y, Kennelly M. Karsenty G, et al. Among authors: schulte baukloh h. Prog Urol. 2014 Nov;24(13):841. doi: 10.1016/j.purol.2014.08.128. Epub 2014 Oct 30. Prog Urol. 2014. PMID: 26461654 French. No abstract available.
Le traitement par onabotulinumtoxin A (BOTOX(®)) améliore l'incontinence urinaire et la qualité de vie des patients porteurs d'hyperactivité Vésicale idiopathique indépendamment des infections urinaires ou du recours à l'autosondage.
Chartier-Kastler E, Everaert K, Gruenenfelder J, Schulte-Baukloh H, Guard S, Zheng Y, Sussman D. Chartier-Kastler E, et al. Among authors: schulte baukloh h. Prog Urol. 2014 Nov;24(13):797-8. doi: 10.1016/j.purol.2014.08.036. Epub 2014 Oct 30. Prog Urol. 2014. PMID: 26461561 French. No abstract available.
53 results